🚀
Enjoy a 7-Day Free Trial Thru Apr 27, 2024!
✨
Sign Up
Login
Free Sign-up
Login
7-Day Free Trial
Home
Homepage
Membership Levels
About Us
General Discussion
Complete Stock List
The book
Membership Data Coverage
Founder's Message
Free Trial
Referral Program
Partner Program
GuruFocus Podcast
Screeners
GuruFocus Screeners
All-In-One Screener
Ben Graham Lost Formula
Canadian Faster Growers
CEO Buys
CEO Buys after Price Drop > 20%
Dividend Kings 2023
Dividend Aristocrats 2023
Dividend Growth Portfolio
Dividend Income Portfolio
Fast Growers
Good Companies
Hedge Fund Guru Top 10 Aggregated
High Quality
High Quality Low Capex w ROE ROC min
High Quality & Low Capex
High Yield Insider Buys
Historical High Dividend Yields
International Gurus' Top Holdings
James Montier Short Screen
Margin Decliners
Mega Caps
Peter Lynch & Warren Buffett
Peter Lynch Growth w Lower Valuation
Peter Lynch S&L Traded Below Book
PFCF Screener
Piotroski Score Screener
Predictable Growth Companies
Profitable predictable margin expanders
Stocks Sold w less Cash
The Stalwarts
My Screeners
Create My Screener
Value Screens
Stock Ideas
All-In-One Screener
S&P 500 Map
S&P 500 Bubble
S&P 500 Aggregate
Buffett-Munger Screener
Industry Overview
Undervalued Predictable
Benjamin Graham Net-Net
52-week/3Y/5Y Lows
52-week/3Y/5Y Highs
Magic Formula(Greenblatt)
Dividend Stocks
Peter Lynch Screen
S&P500 Grid
Predictable Companies
Spin Off List
Merger and Acquisition List
Historical Low P/B List
Historical Low P/S List
High Short Interest
Upcoming Special Dividends
Delisted Stocks
Model Portfolios
Performances Overview
Most Broadly Held Portfolio
Most Weighted Portfolio
Buffett-Munger Top 25
GF Score <= 100 Top 25
Top 25 Undervalued Predictable
Top 25 52-week Low Predictable
Top 25 Historical Low P/S
Stock Comparison
Airline Stocks
Artificial Intelligence Stocks
Bank Stocks
Biotech Stocks
Blockchain Stocks
Chinese Stocks
Dividend Stocks
EV Stocks
Growth Stocks
Oil Stocks
Value Stocks
Virtual Reality Stocks
Compare More Stocks…
Gurus
Guru Trades
Latest Guru Picks
Real Time Picks
Guru Portfolio
Score Board
Mutual Funds
Top 10 Holdings
Sector Picks
International Picks
Aggregated Portfolio
Consensus Picks
Guru Bargains
Hot Picks
Download Guru Portfolios
Industry Trends
Geographic Trend
ETFs
Options Holdings
European Shorting
Guru Lists
Complete Guru List
Warren Buffett
Bill Gates
Mohnish Pabrai
Carl Icahn
George Soros
David Tepper
Seth Klarman
Bill Ackman
Joel Greenblatt
Charlie Munger
Michael Price
Julian Robertson
Chuck Akre
David Einhorn
Tom Gayner
My Guru Lists
Insiders
Insider Trading Tracker
Real-Time Insider Picks
CEO Buys/Sells
CFO Buys/Sells
Insider Trends
Insider Cluster
Guru + Insider Double Buys
Triple Buys/Sells
Chinese Insider
German Insider
Complete Insider List
Politician Trading Tracker
Real-Time Politician Picks
Complete Politician List
Nancy Pelosi
Mitch Mcconnell
Tommy Tuberville
Josh Gottheimer
Kevin Hern
Thomas R. Carper
Susie Lee
Lois Frankel
Market
US Market Valuation
Buffett Indicator
U.S. Treasury Yield Curve
U.S. Inflation Rate
Presidential Cycle and Stock Market
Shiller P/E
Shiller P/E by Sectors
GF Value for S&P 500 Index
Fed Net Liquidity
Buffett Assets Allocation
Latest IPOs
Global Market Valuation
Global Market Overview
USA
China
Japan
India
Canada
UK
France
Germany
Brazil
Australia
More...
Economic Indicators
Economic Indicators Overview
The Dow Jones Industrial Average (DJIA)
SP 500 Index
Nasdaq Composite Index
Gross Domestic Product (GDP)
Shiller PE
Ratio of Wilshire 5000 over GNP
Civilian Unemployment Rate
Russell 2000 Index
CBOE Volatility Index (VIX)
Total Nonfarm Payrolls: All Employees
More...
Sector & Industry Performance
Global Industry Overview
USA
Asia
Europe
Canada
UK/Ireland
Oceania
Latin America
Africa
India/Pakistan
Articles
Articles
Editors' Picks
Stock Market News
Q&A with Gurus
Guru Stock Picks
Insider Transaction
Earning Reports
CEO Shareholder Letters
Podcast
Earnings Call Transcripts
Software Stock News
Biotechnology Stock News
Hardware Stock News
Banks Stock News
Metals & Mining Stock News
Drug Manufacturers Stock News
All Articles
Submit Articles
Submit Article Online
Contributor Guidelines
Tools
Model Portfolios
All-In-One Screener
Data Batch Download
Guru Portfolio Download
Insider Data Download
Excel Add-In
Google Sheets Add-On
API
Manual of Stocks
DCF Calculator
WACC Calculator
Interactive Chart
Maps
Fund Letters Archive
Stock Comparison Table
Mobile App
Discussion Board
GuruGPT
Financial Calendar
Embed Widgets
Stock Market Holidays
Discussion
Discussion Board
GuruFocus Discord
ETF
Data
Pricing
Tutorials
Tutorials
Financial Glossary
FAQ
Change Log
Contact Us
Support
Chat Support
Create a ticket
Book Demo
User Engagement Meeting
469-248-6885
Status
Take Survey
Ask the community in Discord
Subscribe
Free Trial
Group Subscription
Refer a Friend and Earn One Month of Free Membership
GURUFOCUS.COM
STOCK LIST
Healthcare
Biotechnology
Homology Medicines Inc (NAS:FIXX)
News
Homology Medicines Inc
NAS
:FIXX (USA) Â
$ 0.93
+0.0071 (+0.77%)
11:09 PM EST
P/E:
At Loss
P/B:
0.04
Market Cap:
$ 3.02M
Enterprise V:
$ -78.32M
Volume:
-
Avg Vol (2M):
34.55K
Warning! GuruFocus detected 5 Severe warning signs with FIXX.
Try a 7-Day Free Trial
to check it out.
Also Trade In:
Volume:
-
Market Cap $:
3.02M
PE Ratio:
At Loss
Avg Vol (2M):
34.55K
Enterprise Value $:
-78.32M
PB Ratio:
0.04
Alerts
Website
SEC Filings
Stock PDF
Dataset
Financial Download
Manual of Stocksâ„¢
Compare
0
Summary
30-Y Financials
Estimates
DCF
Dividend
Guru Trades
Insider
Interactive Chart
Filings
Transcripts
News
Compare
Stock PDF
Ownership
Operating
Checklist
Vote
Definitions
Homology Medicines Inc (NAS:FIXX) Stock News, Headlines & Updates
Homology Medicines Inc Stock News from GuruFocus
Total 201
1
2
3
4
5
6
Feb 27, 2024
HOMOLOGY MEDICINES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Homology Medicines, Inc. - FIXX
Business Wire
•
3:00pm
Feb 07, 2024
Homology Medicines Inc to Announce Encouraging First Dose Level Initial Data Call Transcript
GuruFocus Research
•
7:01pm
Homology Medicines Inc Annual Shareholders Meeting Transcript
GuruFocus Research
•
7:01pm
Homology Medicines Inc at Stifel Healthcare Conference Transcript
GuruFocus Research
•
7:01pm
Homology Medicines Inc Annual Shareholders Meeting Transcript
GuruFocus Research
•
7:01pm
Homology Medicines Inc ASGCT Symposium Transcript
GuruFocus Research
•
7:01pm
Homology Medicines Inc at Needham Healthcare Conference (Virtual) Transcript
GuruFocus Research
•
7:01pm
Homology Medicines Inc to Discuss Transaction with Oxford Biomedica and Provide an Update on Clinical Programs and Product Pipeline Transcript
GuruFocus Research
•
7:01pm
Homology Medicines Inc at Credit Suisse Healthcare Conference (Virtual) Transcript
GuruFocus Research
•
7:01pm
Homology Medicines Inc at Alliance for Regenerative Medicine Cell & Gene Meeting on the Mesa (Virtual) Transcript
GuruFocus Research
•
7:01pm
Homology Medicines Inc at Bank of America NAPA Healthcare Conference Transcript
GuruFocus Research
•
7:01pm
Homology Medicines Inc Corporate and Pipeline Updates Transcript
GuruFocus Research
•
7:01pm
Homology Medicines Inc At Cell Gene Meeting on the Mesa Transcript
GuruFocus Research
•
7:01pm
Homology Medicines Inc at Alliance for Regenerative Medicine Cell & Gene Meeting on the Mesa (Virtual) Transcript
GuruFocus Research
•
7:01pm
Homology Medicines Inc To Host Emerging Therapies and Clinical Trials Event Transcript
GuruFocus Research
•
7:01pm
Nov 21, 2023
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MIRO, SRC, PATI, FIXX
PRNewswire
•
2:00am
STOCKHOLDER ALERT: The M&A Class Action Firm Continues Investigating the Merger - NGAB, PFIN, SRT, FIXX
PRNewswire
•
8:00pm
Nov 18, 2023
HOMOLOGY MEDICINES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Homology Medicines, Inc. - FIXX
Business Wire
•
6:00pm
Nov 16, 2023
FIXX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Homology Medicines, Inc. Is Fair to Shareholders
Business Wire
•
12:00pm
Q32 Bio and Homology Medicines Announce Merger Agreement
PRNewswire
•
7:00am
Aug 16, 2023
SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Homology Medicines, Inc. (NASDAQ: FIXX) and Encourages Long-Term Investors to Contact the Firm - FIXX
PRNewswire
•
10:00am
Aug 14, 2023
Homology Medicines Reports Second Quarter 2023 Financial Results and Recent Highlights
Marketwired
•
4:00pm
Jul 27, 2023
Homology Medicines Announces Plan to Evaluate Strategic Options for the Company and its Genetic Medicines Programs, including HMI-103 Gene Editing Candidate for PKU
Marketwired
•
4:00pm
Homology Medicines Announces Encouraging Initial Data from First Dose Level in the pheEDIT Trial Evaluating Gene Editing Candidate HMI-103 in Adults with Classical PKU
Marketwired
•
4:00pm
Mar 02, 2023
Homology Medicines to Participate in the 43rd Annual Cowen Healthcare Conference
sperokesalga
•
7:00am
Oct 27, 2022
Homology Medicines Presents on Design of pheEDIT Trial Evaluating One-Time Nuclease-Free Gene Editing Candidate HMI-103 for PKU at American Society of Human Genetics Meeting
Value_Insider
•
9:00am
Jul 15, 2022
Homology Medicines Announces Peer-Reviewed Publication on Novel Discovery of AAVHSC with Robust Distribution to the Central Nervous System and Peripheral Organs with Low Affinity for the Liver
PurpleRose
•
7:40am
Jul 12, 2022
HOMOLOGY MEDICINES, INC. Investors: Contact the Portnoy Law Firm to Recover Losses
PurpleRose
•
9:07pm
Jul 09, 2022
FIXX FINAL DEADLINE TUESDAY: ROSEN, A LEADING LAW FIRM, Encourages Homology Medicines, Inc. Investors with Losses to Secure Counsel Before Important Tuesday Deadline in Securities Class Action – FIXX
GuruFocusNews
•
5:14pm
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Homology Medicines (FIXX) Investors with Significant Losses to Contact Firm's Attorneys Before May 24th Deadline in Securities Class Action
GuruFocusNews
•
4:15pm
Homology Medicines to Present at Upcoming Conferences on its Gene Editing and Gene Therapy Programs for PKU
GuruFocusNews
•
7:38am
HOMOLOGY MEDICINES, INC. (NASDAQ: FIXX) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Homology Medicines, Inc. (NASDAQ: FIXX)
GuruFocusNews
•
3:03am
Jul 08, 2022
ROSEN, LEADING INVESTOR COUNSEL, Encourages Homology Medicines, Inc. Investors with Losses to Secure Counsel Before Important May 24 Deadline in Securities Class Action – FIXX
GuruFocusNews
•
6:03pm
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Homology Medicines (FIXX) Investors with Significant Losses to Contact Firm's Attorneys, May 24th Deadline Approaching in Securities Class Action
GuruFocusNews
•
1:02pm
Jul 05, 2022
Homology Medicines Announces Peer-Reviewed Publication on Novel Discovery of AAVHSC with Robust Distribution to the Central Nervous System and Peripheral Organs with Low Affinity for the Liver
GuruFocusNews
•
7:35am
Jul 02, 2022
HOMOLOGY MEDICINES, INC. Investors: Contact the Portnoy Law Firm to Recover Losses
GuruFocusNews
•
8:07pm
Jun 29, 2022
FIXX FINAL DEADLINE TUESDAY: ROSEN, A LEADING LAW FIRM, Encourages Homology Medicines, Inc. Investors with Losses to Secure Counsel Before Important Tuesday Deadline in Securities Class Action – FIXX
GuruFocusNews
•
5:14pm
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Homology Medicines (FIXX) Investors with Significant Losses to Contact Firm's Attorneys Before May 24th Deadline in Securities Class Action
GuruFocusNews
•
4:14pm
Homology Medicines to Present at Upcoming Conferences on its Gene Editing and Gene Therapy Programs for PKU
GuruFocusNews
•
7:33am
HOMOLOGY MEDICINES, INC. (NASDAQ: FIXX) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Homology Medicines, Inc. (NASDAQ: FIXX)
GuruFocusNews
•
3:03am
Total 201
1
2
3
4
5
6
Show
20
40
60
80
100
No data
Entries
Headlines
Total 0
1
No recent news